Downloads
Article: The Industry Outlook For 2010
By Billy Tauzin President and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)
What is the 2010 outlook for America's pharmaceutical research and biotechnology companies? Well, there's no easy answer. What we can say is that 2010 looks to be a critical year that could help determine the future course for the industry for years to come. America's biopharmaceutical research companies have a long history of developing medicines to help patients live longer, healthier, more productive lives. As companies in the business of helping to improve health, they have also been long committed to efforts to improve patient access to needed care, as well as maintaining and even enhancing the economic and regulatory environment that inspires and rewards innovation and risky investment in new research and development.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Pharmaceutical Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
